PerkinElmer, Inc.
Apr 9, 2010
PDF

PerkinElmer Highlights New Drug Discovery Solutions at SBS 2010

PHOENIX - PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced its latest drug discovery solutions for global research institutions and biopharmaceutical companies at the Society for Biomolecular Sciences 2010, April 11-15 at Booth 701.

PerkinElmer will be showcasing several new drug discovery technologies and applications - including new Alpha technologies, additional ready-to-use GPCR frozen cells and radiochemicals compounds - that are designed to help scientists gain further research insights into numerous disease states, offering new possibilities for drug discovery.

PerkinElmer's new technologies on display at SBS Booth 701 include: